FAP and breast carcinoma: Based on a recent study comprising integrated analysis of single-cell RNA sequencing data, clinical specimens, in vivo, and in vitro experiments, FAP+ CAFs have been identified as the predominant stromal population associated with poor clinical outcomes and immunosuppressive features in breast cancer patients.